One of the world’s largest pharmaceutical companies has halted sales of its popular weight-loss injection in the UK, as demand surges ahead of an imminent price increase.
Eli Lilly, the manufacturer of Mounjaro, has temporarily suspended deliveries of the drug to UK pharmacies in response to “unprecedented demand”.